TransMedics (TMDX) Change in Receivables (2018 - 2026)

TransMedics' Change in Receivables history runs 9 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• On a quarterly basis, Change in Receivables fell 85.23% year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was -$51.6 million, a 185.89% decrease from a year earlier, with the FY2025 full-year figure at -$14.0 million, down 140.66% from the prior year.
• Change in Receivables rose to $6.5 million in Q1 2026 per TMDX's latest filing, from $3.6 million in the prior quarter.
• Across five years, Change in Receivables topped out at $44.1 million in Q1 2025 and bottomed at -$37.5 million in Q2 2025.
• The 5-year median for Change in Receivables is $6.5 million (2026), against an average of $4.8 million.
• Across the five-year window, Change in Receivables soared 895.54% in 2022 and slumped 4856.14% in 2025, its largest moves.
• Year by year, Change in Receivables stood at $5.4 million in 2022, then slumped by 47.71% to $2.8 million in 2023, then surged by 178.15% to $7.8 million in 2024, then slumped by 54.32% to $3.6 million in 2025, then surged by 82.02% to $6.5 million in 2026.
• Per Business Quant, the three latest TMDX Change in Receivables figures stand at $6.5 million (Q1 2026), $3.6 million (Q4 2025), and -$24.1 million (Q3 2025).